Tisagenlecleucel

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
(TIH-suh-jen-lek-LOO-sel)

This page contains brief information about tisagenlecleucel and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Kymriah
FDA Approved
Yes

FDA Approval for Tisagenlecleucel

Use in Cancer

Tisagenlecleucel is approved to treat:

Tisagenlecleucel is only available as part of a special program called Kymriah REMS (Risk Evaluation and Mitigation Strategies).

Tisagenlecleucel is also being studied in the treatment of other types of cancer.

More About Tisagenlecleucel

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Biological Therapies for Cancer

CAR T-Cell Therapy Approved for Some Children and Young Adults with Leukemia

CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers

Clinical Trials Accepting Patients

Find Clinical Trials for Tisagenlecleucel - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: September 1, 2017
  • Updated: September 13, 2017